Product Information
FEBUXOSTAT 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2128 per EA under NDC 59651011330. Its NADAC has been published 124 times since Feb 14, 2024.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651011330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA210741On Market Since
10/25/2023
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 40 MG TABLET has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2128 per EA |
|---|---|
| All-time high | $0.5086 (Apr 10, 2024) |
| All-time low | $0.2016 (Jan 21, 2026) |
| 52-week high | $0.3713 |
| 52-week low | $0.2016 |
| Median price | $0.3315 |
| Average price | $0.3179 |
| Largest weekly change | -29.6% (Apr 17, 2024) |
| Weeks tracked | 124 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2128 per EA (NDC 59651011330), effective Jun 24, 2026.
How has the price of FEBUXOSTAT 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 40 MG TABLET has declined 47.4%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 40 MG TABLET?
Since Feb 14, 2024, the NADAC for FEBUXOSTAT 40 MG TABLET has ranged from a low of $0.2016 (Jan 21, 2026) to a high of $0.5086 (Apr 10, 2024), with a median of $0.3315 per EA.
Are there cheaper alternatives to FEBUXOSTAT 40 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as FEBUXOSTAT 40 MG TABLET, but none are currently priced below it.
Who manufactures FEBUXOSTAT 40 MG TABLET?
FEBUXOSTAT 40 MG TABLET (NDC 59651011330) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification